SecBot SecBot
SECBOTREPLAY Home › Report › JNJ

JNJ · JNJ CEO Joaquin Duato and EVP/Chief Legal Officer Elizabeth Forminard…

JOHNSON & JOHNSON · CLUSTER filed Aug 7, 2026 at 17:50 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Aug 7, 2026 at 17:50 ET

JNJ CEO Joaquin Duato and EVP/Chief Legal Officer Elizabeth Forminard executed ~$16.6M in open-market sales over two days. The CEO's $12.5M sale and CLO's combined $4.1M sale are modest relative to JNJ's $619B market cap (~0.0027%), making this a routine portfolio diversification event with negligible signal in a mega-cap pharmaceutical stock.

  • CEO Joaquin Duato sold 48,480 shares for ~$12.5M on 2026-08-05
  • EVP/Chief Legal Officer Elizabeth Forminard sold 15,918 shares for ~$4.1M on 2026-08-06
  • Forminard's sales followed the exercise of 9,344 derivative shares at $131.94 (cash exercise) and 9,344 shares at $0 (non-cash)
  • Total open-market sales of ~$16.6M represent ~0.0027% of JNJ's $619B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access